loading
Schlusskurs vom Vortag:
$32.94
Offen:
$33.3
24-Stunden-Volumen:
809.61K
Relative Volume:
2.60
Marktkapitalisierung:
$1.12B
Einnahmen:
$566.77M
Nettoeinkommen (Verlust:
$48.16M
KGV:
29.35
EPS:
1.19
Netto-Cashflow:
$274.29M
1W Leistung:
+16.16%
1M Leistung:
+10.64%
6M Leistung:
+13.34%
1J Leistung:
-1.10%
1-Tages-Spanne:
Value
$33.28
$34.99
1-Wochen-Bereich:
Value
$29.70
$34.99
52-Wochen-Spanne:
Value
$23.23
$42.29

Collegium Pharmaceutical Inc Stock (COLL) Company Profile

Name
Firmenname
Collegium Pharmaceutical Inc
Name
Telefon
781-713-3699
Name
Adresse
100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA
Name
Mitarbeiter
357
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
COLL's Discussions on Twitter

Vergleichen Sie COLL mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - Specialty & Generic icon
COLL
Collegium Pharmaceutical Inc
34.93 956.23M 566.77M 48.16M 274.29M 1.19
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
147.35 64.93B 9.39B 2.61B 2.22B 5.81
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.44 45.07B 29.98B 958.27M 5.31B 0.2964
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.54 41.53B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.37 18.37B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
301.50 13.68B 2.99B 1.21B 1.13B 25.06

Collegium Pharmaceutical Inc Stock (COLL) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-01-10 Hochstufung Needham Hold → Buy
2024-07-30 Hochstufung H.C. Wainwright Neutral → Buy
2024-06-07 Hochstufung Jefferies Hold → Buy
2024-05-10 Herabstufung Needham Buy → Hold
2024-05-10 Herabstufung Piper Sandler Overweight → Neutral
2024-01-04 Herabstufung Jefferies Buy → Hold
2023-08-25 Bestätigt Needham Buy
2023-05-02 Fortgesetzt Jefferies Buy
2022-08-08 Herabstufung H.C. Wainwright Buy → Neutral
2022-02-15 Hochstufung Cantor Fitzgerald Neutral → Overweight
2021-08-06 Herabstufung Cantor Fitzgerald Overweight → Neutral
2021-01-11 Bestätigt H.C. Wainwright Buy
2020-07-14 Eingeleitet BWS Financial Sell
2020-05-27 Eingeleitet Guggenheim Neutral
2020-02-19 Fortgesetzt Jefferies Buy
2019-10-30 Bestätigt Needham Buy
2019-05-03 Fortgesetzt H.C. Wainwright Buy
2019-04-12 Fortgesetzt Janney Buy
2019-03-20 Eingeleitet SunTrust Hold
2019-01-16 Bestätigt Needham Buy
2018-03-08 Bestätigt H.C. Wainwright Buy
2018-02-07 Bestätigt Needham Buy
2017-12-05 Bestätigt Needham Buy
2017-09-11 Eingeleitet H.C. Wainwright Buy
2017-05-11 Bestätigt Needham Buy
2016-09-13 Eingeleitet Gabelli & Co Buy
2015-06-01 Eingeleitet Jefferies Buy
2015-06-01 Eingeleitet Needham Buy
2015-06-01 Eingeleitet Piper Jaffray Overweight
Alle ansehen

Collegium Pharmaceutical Inc Aktie (COLL) Neueste Nachrichten

pulisher
03:03 AM

Collegium Pharmaceutical (COLL) Is Up 16.2% After Raising 2025 Revenue Guidance on Strong Q2 Results - simplywall.st

03:03 AM
pulisher
Aug 10, 2025

Collegium Pharmaceutical's Q2 2025: Key Contradictions on Jornay PM Sales Estimates and Pain Portfolio Competition - AInvest

Aug 10, 2025
pulisher
Aug 10, 2025

Collegium Pharmaceutical (NASDAQ:COLL) Upgraded by Wall Street Zen to Strong-Buy Rating - MarketBeat

Aug 10, 2025
pulisher
Aug 09, 2025

Collegium Pharmaceutical Reports Record Q2 2025 Revenue, Raises Outlook and Initiates $150M Share Repurchase Program - AInvest

Aug 09, 2025
pulisher
Aug 08, 2025

Why Collegium Pharmaceutical (COLL) Rose 10.3% After Raising 2025 Revenue Guidance Despite Lower Earnings - simplywall.st

Aug 08, 2025
pulisher
Aug 08, 2025

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q2 2025 Earnings Call Transcript - Insider Monkey

Aug 08, 2025
pulisher
Aug 08, 2025

Collegium Pharmaceutical: Q2 Earnings Snapshot - Greenwich Time

Aug 08, 2025
pulisher
Aug 08, 2025

Collegium Pharmaceutical Reports Strong Q2 2025 Results - TipRanks

Aug 08, 2025
pulisher
Aug 07, 2025

Collegium Pharmaceuticals Reports Strong Earnings and Growth - TipRanks

Aug 07, 2025
pulisher
Aug 07, 2025

Collegium Pharmaceutical’s Strong Financial Performance and Strategic Growth Initiatives Justify Buy Rating - TipRanks

Aug 07, 2025
pulisher
Aug 07, 2025

Truist Securities raises Collegium Pharmaceutical stock price target to $45 By Investing.com - Investing.com UK

Aug 07, 2025
pulisher
Aug 07, 2025

Collegium Pharmaceutical (NASDAQ:COLL) Exceeds Q2 Expectations, Stock Jumps 10.2% - FinancialContent

Aug 07, 2025
pulisher
Aug 07, 2025

Collegium raises 2025 revenue guidance to $760M as Jornay PM growth accelerates - MSN

Aug 07, 2025
pulisher
Aug 07, 2025

Collegium Pharmaceutical Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 07, 2025
pulisher
Aug 07, 2025

Collegium Pharmaceutical Q2 2025 slides: Revenue surges 29%, guidance raised - Investing.com

Aug 07, 2025
pulisher
Aug 07, 2025

Collegium Pharmaceutical (COLL) Q2 Earnings and Revenues Surpass Estimates - sharewise.com

Aug 07, 2025
pulisher
Aug 07, 2025

Compared to Estimates, Collegium Pharmaceutical (COLL) Q2 Earnings: A Look at Key Metrics - Yahoo Finance

Aug 07, 2025
pulisher
Aug 07, 2025

SIXS ETF Implied Analyst Target Price: $58.24 - AInvest

Aug 07, 2025
pulisher
Aug 07, 2025

Collegium Pharmaceutical Reports Record Q2 2025 Revenue - TipRanks

Aug 07, 2025
pulisher
Aug 07, 2025

Collegium Pharmaceutical earnings beat by $0.02, revenue topped estimates - Investing.com Canada

Aug 07, 2025
pulisher
Aug 07, 2025

Earnings Flash (COLL) Collegium Pharmaceutical, Inc. Reports Q2 Revenue $188.0M, vs. FactSet Est of $180.9M - MarketScreener

Aug 07, 2025
pulisher
Aug 07, 2025

Earnings Flash (COLL) Collegium Pharmaceutical, Inc. Posts Q2 Adjusted EPS $1.68 per Share, vs. FactSet Est of $1.62 - MarketScreener

Aug 07, 2025
pulisher
Aug 07, 2025

Collegium Reports Second Quarter 2025 Financial Results; Raises 2025 Outlook - GlobeNewswire

Aug 07, 2025
pulisher
Aug 05, 2025

Collegium Pharmaceutical Q2 Earnings: Revenue Expected to Grow 24.2% YoY - AInvest

Aug 05, 2025
pulisher
Aug 05, 2025

Collegium Pharmaceutical (COLL) Q2 Earnings: What To Expect - Yahoo Finance

Aug 05, 2025
pulisher
Aug 05, 2025

Collegium Pharmaceutical is helping individuals with ADHD - KOIN.com

Aug 05, 2025
pulisher
Aug 05, 2025

Collegium Pharmaceuticals is helping those with ADHD - KOIN.com

Aug 05, 2025
pulisher
Aug 04, 2025

Moving Average Crossover Confirms Uptrend in Collegium Pharmaceutical Inc.Breakout Momentum Picks With Protection Outlined - metal.it

Aug 04, 2025
pulisher
Aug 04, 2025

Collegium Pharmaceutical Inc. Rebound Backed by Sentiment ShiftLow Risk High Return Opportunities Identified - metal.it

Aug 04, 2025
pulisher
Aug 04, 2025

Real Time Chart Alerts Flash Bullish on Collegium Pharmaceutical Inc.Trade Ready Stock Watch for Short Term Published - metal.it

Aug 04, 2025
pulisher
Aug 03, 2025

When is Collegium Pharmaceutical Inc. stock expected to show significant growthInvest smarter with comprehensive market analysis - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Does Collegium Pharmaceutical Inc. stock perform well during market downturnsCapitalize on high-yield stocks early - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Is Collegium Pharmaceutical Inc. stock overvalued or undervaluedGet insider insights into market trends - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What is the risk reward ratio of investing in Collegium Pharmaceutical Inc. stockUnlock powerful stock screening for profits - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What catalysts could drive Collegium Pharmaceutical Inc. stock higher in 2025Capitalize on market momentum for profits - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What are Collegium Pharmaceutical Inc. company’s key revenue driversAccess powerful market insights for free - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Is Collegium Pharmaceutical Inc. a good long term investmentAchieve consistent profits with proven methods - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How does Collegium Pharmaceutical Inc. compare to its industry peersMaximize gains with professional stock picks - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How many analysts rate Collegium Pharmaceutical Inc. as a “Buy”Invest in stocks with long-term growth potential - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Collegium Pharmaceutical Inc. Stock Analysis and ForecastAchieve superior capital gains with smart trades - Jammu Links News

Aug 03, 2025
pulisher
Aug 02, 2025

Collegium Pharmaceutical to report Q2 2025 financial results on August 7, 2025. - AInvest

Aug 02, 2025
pulisher
Aug 01, 2025

What are the technical indicators suggesting about Collegium Pharmaceutical Inc.Real Time Tracker With High Returns - Jammu Links News

Aug 01, 2025
pulisher
Aug 01, 2025

Back to School advice to help kids with ADHD Thrive| Talk of Alabama | 8.1.2025 - WBMA

Aug 01, 2025

Finanzdaten der Collegium Pharmaceutical Inc-Aktie (COLL)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$26.71
price up icon 0.43%
$16.67
price up icon 1.15%
$9.70
price up icon 3.30%
drug_manufacturers_specialty_generic RDY
$13.80
price up icon 1.47%
$125.01
price down icon 0.47%
$301.50
price up icon 0.69%
Kapitalisierung:     |  Volumen (24h):